Quantifying and resolving multiple vector transformants in <it>S. cerevisiae </it>plasmid libraries

Por Gray Elizabeth C, Scanlon Thomas C, Griswold Karl E
Publicado em 2009-11-01

Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries

Por Scanlon, Thomas C, Gray, Elizabeth C, Griswold, Karl E
Publicado em 2009

A High-Throughput Screen for Antibiotic Drug Discovery

Por Scanlon, Thomas C., Dostal, Sarah M., Griswold, Karl E.
Publicado em 2013

The monoclonal myth

Por Scanlon, Thomas C, Jewell, Heather L, Gray, Elizabeth C, Griswold, Karl E
Publicado em 2010

Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity

Por Gill, Avinash, Scanlon, Thomas C., Osipovitch, Daniel C., Madden, Dean R., Griswold, Karl E.
Publicado em 2011

Genetically Enhanced Lysozyme Evades a Pathogen Derived Inhibitory Protein

Por Dostal, Sarah M., Fang, Yongliang, Guerrette, Jonathan C., Scanlon, Thomas C., Griswold, Karl E.
Publicado no ACS Chem Biol (2015)

Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity

Por Lamppa, John W., Ackerman, Margaret E., Lai, Jennifer I., Scanlon, Thomas C., Griswold, Karl E.
Publicado em 2011

Bioengineered Lysozyme Reduces Bacterial Burden and Inflammation in a Murine Model of Mucoid Pseudomonas aeruginosa Lung Infection

Por Teneback, Charlotte C., Scanlon, Thomas C., Wargo, Matthew J., Bement, Jenna L., Griswold, Karl E., Leclair, Laurie W.
Publicado em 2013

Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections

Por Griswold, Karl E, Bement, Jenna L, Teneback, Charlotte C, Scanlon, Thomas C, Wargo, Matthew J, Leclair, Laurie W
Publicado em 2014

Enhanced antimicrobial activity of engineered human lysozyme

Por Scanlon, Thomas C., Teneback, Charlotte C., Gill, Avinash, Bement, Jenna L., Weiner, Joshua A., Lamppa, John W., Leclair, Laurie W., Griswold, Karl E.
Publicado em 2010